Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis

Endocrine

Volumn 53, Issue 1, 2016, Pages 227-239

  Spanakis, Elias K ^a   Wang, Xu ^c   Sánchez, Brisa N ^d   Diez Roux, Ana V ^c   Needham, Belinda L ^d   Wand, Gary S ^a   Seeman, Teresa ^e   Golden, Sherita Hill ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c DREXEL UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cortisol; Diabetes; Epidemiology; HPA axis; Stress

Indexed keywords

HYDROCORTISONE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ATHEROSCLEROSIS; CAUCASIAN; CIRCADIAN RHYTHM; COHORT ANALYSIS; COMMUNITY LIVING; CONTROLLED STUDY; CORTISOL AWAKENING RESPONSE; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SALIVA LEVEL; UNITED STATES; CHEMISTRY; CROSS-SECTIONAL STUDY; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SALIVA;

AGED; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SALIVA;

EID: 84958742814     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-016-0887-8     Document Type: Article

References (52)

1. P.M. Peeke, G.P. Chrousos, Hypercortisolism and obesity. Ann. N. Y. Acad. Sci. 771, 665–676 (1995)
2. G. Mazziotti, C. Gazzaruso, A. Giustina, Diabetes in cushing syndrome: basic and clinical aspects. TEM 22(12), 499–506 (2011). doi:10.1016/j.tem.2011.09.001
3. P. Anagnostis, V.G. Athyros, K. Tziomalos, A. Karagiannis, D.P. Mikhailidis, Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J. Clin. Endocrinol. Metab. 94(8), 2692–2701 (2009). doi:10.1210/jc.2009-0370
4. H. Bruehl, M. Rueger, I. Dziobek, V. Sweat, A. Tirsi, E. Javier, A. Arentoft, O.T. Wolf, A. Convit, Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. J. Clin. Endocrinol. Metab. 92(7), 2439–2445 (2007). doi:10.1210/jc.2006-2540
5. I. Chiodini, M. Torlontano, A. Scillitani, M. Arosio, S. Bacci, S. Di Lembo, P. Epaminonda, G. Augello, R. Enrini, B. Ambrosi, G. Adda, V. Trischitta, Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur. J. Endocrinol. 153(6), 837–844 (2005). doi:10.1530/eje.1.02045
6. A.F. Godoy-Matos, A.R. Vieira, R.O. Moreira, W.F. Coutinho, L.M. Carraro, D.M. Moreira, R. Pasquali, R.M. Meirelles, The potential role of increased adrenal volume in the pathophysiology of obesity-related type 2 diabetes. J. Endocrinol. Invest. 29(2), 159–163 (2006)
7. S. Champaneri, X. Xu, M.R. Carnethon, A.G. Bertoni, T. Seeman, A.S. DeSantis, A. Diez Roux, S. Shrager, S.H. Golden, Diurnal salivary cortisol is associated with body mass index and waist circumference: the multiethnic study of atherosclerosis. Obesity 21(1), E56–E63 (2013). doi:10.1002/oby.20047
8. R. Rosmond, S. Wallerius, P. Wanger, L. Martin, G. Holm, P. Bjorntorp, A 5-year follow-up study of disease incidence in men with an abnormal hormone pattern. J. Intern. Med. 254(4), 386–390 (2003)
9. A. Gungunes, M. Sahin, T. Demirci, B. Ucan, E. Cakir, M.S. Arslan, I.O. Unsal, B. Karbek, M. Caliskan, M. Ozbek, E. Cakal, T. Delibasi, Cushing’s syndrome in type 2 diabetes patients with poor glycemic control. Endocrine 47(3), 895–900 (2014). doi:10.1007/s12020-014-0260-8
10. B. Catargi, V. Rigalleau, A. Poussin, N. Ronci-Chaix, V. Bex, V. Vergnot, H. Gin, P. Roger, A. Tabarin, Occult Cushing’s syndrome in type-2 diabetes. J. Clin. Endocrinol. Metab. 88(12), 5808–5813 (2003). doi:10.1210/jc.2003-030254
11. L. Wei, T.M. MacDonald, B.R. Walker, Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann. Intern. Med. 141(10), 764–770 (2004)
12. P.C. Souverein, A. Berard, T.P. Van Staa, C. Cooper, A.C. Egberts, H.G. Leufkens, B.R. Walker, Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 90(8), 859–865 (2004). doi:10.1136/hrt.2003.020180
13. J. Etxabe, J.A. Vazquez, Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin. Endocrinol. 40(4), 479–484 (1994)
14. N.M. Neary, O.J. Booker, B.S. Abel, J.R. Matta, N. Muldoon, N. Sinaii, R.I. Pettigrew, L.K. Nieman, A.M. Gharib, Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography. J. Clin. Endocrinol. Metab. 98(5), 2045–2052 (2013). doi:10.1210/jc.2012-3754
15. S. Champaneri, G.S. Wand, S.S. Malhotra, S.S. Casagrande, S.H. Golden, Biological basis of depression in adults with diabetes. Curr. Diab. Rep. 10(6), 396–405 (2010). doi:10.1007/s11892-010-0148-9
16. P.E. Szmitko, C.H. Wang, R.D. Weisel, J.R. de Almeida, T.J. Anderson, S. Verma, New markers of inflammation and endothelial cell activation: part I. Circulation 108(16), 1917–1923 (2003). doi:10.1161/01.CIR.0000089190.95415.9F
17. P.M. Ridker, J.E. Buring, J. Shih, M. Matias, C.H. Hennekens, Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98(8), 731–733 (1998)
18. J.C. Pruessner, O.T. Wolf, D.H. Hellhammer, A. Buske-Kirschbaum, K. von Auer, S. Jobst, F. Kaspers, C. Kirschbaum, Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 61(26), 2539–2549 (1997)
19. C. Kirschbaum, D.H. Hellhammer, Salivary cortisol in psychobiological research: an overview. Neuropsychobiology 22(3), 150–169 (1989).
20. A.S. Karlamangla, E.M. Friedman, T.E. Seeman, R.S. Stawksi, D.M. Almeida, Daytime trajectories of cortisol: demographic and socioeconomic differences—findings from the National Study of Daily Experiences. Psychoneuroendocrinology 38(11), 2585–2597 (2013). doi:10.1016/j.psyneuen.2013.06.010
21. S.E. Sephton, R.M. Sapolsky, H.C. Kraemer, D. Spiegel, Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 92(12), 994–1000 (2000)
22. E.K. Adam, M.R. Gunnar, Relationship functioning and home and work demands predict individual differences in diurnal cortisol patterns in women. Psychoneuroendocrinology 26(2), 189–208 (2001)
23. M.R. Gunnar, D.M. Vazquez, Low cortisol and a flattening of expected daytime rhythm: potential indices of risk in human development. Dev. Psychopathol. 13(3), 515–538 (2001)
24. S.R. Kunz-Ebrecht, C. Kirschbaum, M. Marmot, A. Steptoe, Differences in cortisol awakening response on work days and weekends in women and men from the Whitehall II cohort. Psychoneuroendocrinology 29(4), 516–528 (2004)
25. C.E. Wright, A. Steptoe, Subjective socioeconomic position, gender and cortisol responses to waking in an elderly population. Psychoneuroendocrinology 30(6), 582–590 (2005). doi:10.1016/j.psyneuen.2005.01.007
26. S. Cohen, J.E. Schwartz, E. Epel, C. Kirschbaum, S. Sidney, T. Seeman, Socioeconomic status, race, and diurnal cortisol decline in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Psychosom. Med. 68(1), 41–50 (2006). doi:10.1097/01.psy.0000195967.51768.ea
27. D.E. Saxbe, R.L. Repetti, A. Nishina, Marital satisfaction, recovery from work, and diurnal cortisol among men and women. Health Psychol. 27(1), 15–25 (2008). doi:10.1037/0278-6133.27.1.15
28. A. Hajat, A. Diez-Roux, T.G. Franklin, T. Seeman, S. Shrager, N. Ranjit, C. Castro, K. Watson, B. Sanchez, C. Kirschbaum, Socioeconomic and race/ethnic differences in daily salivary cortisol profiles: the multi-ethnic study of atherosclerosis. Psychoneuroendocrinology 35(6), 932–943 (2010). doi:10.1016/j.psyneuen.2009.12.009
29. M. Kumari, M. Shipley, M. Stafford, M. Kivimaki, Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II study. J. Clin. Endocrinol. metab. 96(5), 1478–1485 (2011). doi:10.1210/jc.2010-2137
30. X. Wang, B.N. Sanchez, S.H. Golden, S. Shrager, C. Kirschbaum, A.S. Karlamangla, T.E. Seeman, A.V. Roux, Stability and predictors of change in salivary cortisol measures over six years: MESA. Psychoneuroendocrinology 49, 310–320 (2014). doi:10.1016/j.psyneuen.2014.07.024
31. S.H. Golden, B.N. Sanchez, M. Wu, S. Champaneri, A.V. Diez Roux, T. Seeman, G.S. Wand, Relationship between the cortisol awakening response and other features of the diurnal cortisol rhythm: the Multi-Ethnic Study of Atherosclerosis. Psychoneuroendocrinology 38(11), 2720–2728 (2013). doi:10.1016/j.psyneuen.2013.06.032
32. S.H. Golden, G.S. Wand, S. Malhotra, I. Kamel, K. Horton, Reliability of hypothalamic-pituitary-adrenal axis assessment methods for use in population-based studies. Eur. J. Epidemiol. 26(7), 511–525 (2011). doi:10.1007/s10654-011-9585-2
33. G. Tirabassi, M. Boscaro, G. Arnaldi, Harmful effects of functional hypercortisolism: a working hypothesis. Endocrine 46(3), 370–386 (2014). doi:10.1007/s12020-013-0112-y
34. J.J. Joseph, X. Wang, E. Spanakis, T. Seeman, G. Wand, B. Needham, S.H. Golden, Diurnal salivary cortisol, glycemia and insulin resistance: the multi-ethnic study of atherosclerosis. Psychoneuroendocrinology 62, 327–335 (2015). doi:10.1016/j.psyneuen.2015.08.021
35. D.E. Bild, D.A. Bluemke, G.L. Burke, R. Detrano, A.V. Diez Roux, A.R. Folsom, P. Greenland, D.R. Jacob Jr, R. Kronmal, K. Liu, J.C. Nelson, D. O’Leary, M.F. Saad, S. Shea, M. Szklo, R.P. Tracy, Multi-ethnic study of atherosclerosis: objectives and design. Am. J. Epidemiol. 156(9), 871–881 (2002)
36. H. Raff, Update on late-night salivary cortisol for the diagnosis of Cushing’s syndrome: methodological considerations. Endocrine 44(2), 346–349 (2013). doi:10.1007/s12020-013-0013-0
37. G. Bellastella, M.I. Maiorino, A. De Bellis, M.T. Vietri, C. Mosca, L. Scappaticcio, D. Pasquali, K. Esposito, D. Giugliano, Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes. Endocrine (2015). doi:10.1007/s12020-015-0777-5
38. S. Hill Golden, B.N. Sanchez, A.S. Desantis, M. Wu, C. Castro, T.E. Seeman, S. Tadros, S. Shrager, A.V. Diez Roux, Salivary cortisol protocol adherence and reliability by socio-demographic features: the Multi-Ethnic Study of Atherosclerosis. Psychoneuroendocrinology 43, 30–40 (2014). doi:10.1016/j.psyneuen.2014.01.025
39. D.H. Hellhammer, S. Wust, B.M. Kudielka, Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology 34(2), 163–171 (2009). doi:10.1016/j.psyneuen.2008.10.026
40. K.C. Yeh, K.C. Kwan, A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation. J. Pharmacokinet. Biopharm. 6(1), 79–98 (1978)
41. E. Badrick, C. Kirschbaum, M. Kumari, The relationship between smoking status and cortisol secretion. J. Clin. Endocrinol. metab. 92(3), 819–824 (2007). doi:10.1210/jc.2006-2155
42. A.G. Bertoni, M.C. Whitt-Glover, H. Chung, K.Y. Le, R.G. Barr, M. Mahesh, N.S. Jenny, G.L. Burke, D.R. Jacobs, The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Am. J. Epidemiol. 169(4), 444–454 (2009). doi:10.1093/aje/kwn350
43. L. Radloff, The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1, 385–401 (1977)
44. P.A. Pilkonis, S.D. Imber, P. Rubinsky, Dimensions of life stress in psychiatric patients. J. Human Stress 11(1), 5–10 (1985). doi:10.1080/0097840X.1985.9936732
45. M.S. Mujahid, A.V. Diez Roux, R.C. Cooper, S. Shea, D.R. Williams, Neighborhood stressors and race/ethnic differences in hypertension prevalence (the Multi-Ethnic Study of Atherosclerosis). Am. J. Hypertens. 24(2), 187–193 (2011). doi:10.1038/ajh.2010.200
46. E.K. Adam, M. Kumari, Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology 34(10), 1423–1436 (2009). doi:10.1016/j.psyneuen.2009.06.011
47. S. Champaneri, X. Xu, M.R. Carnethon, A.G. Bertoni, T. Seeman, A. Diez Roux, S.H. Golden, Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis. Metabolism 61(7), 986–995 (2012). doi:10.1016/j.metabol.2011.11.006
48. G. Casella, R. Berger, Statistical Inference, vol. 2 (Duxbury Press, Pacific Grove, 2001)
49. H. Bruehl, O.T. Wolf, A. Convit, A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology 34(6), 815–821 (2009). doi:10.1016/j.psyneuen.2008.12.010
50. F. Lederbogen, J. Hummel, C. Fademrecht, B. Krumm, C. Kuhner, M. Deuschle, K.H. Ladwig, C. Meisinger, H.E. Wichmann, H. Lutz, B. Breivogel, Flattened circadian cortisol rhythm in type 2 diabetes. Exp. Clin. Endocrinol. Diabet. 119(9), 573–575 (2011). doi:10.1055/s-0031-1275288
51. S.A. Vreeburg, B.P. Kruijtzer, J. van Pelt, R. van Dyck, R.H. DeRijk, W.J. Hoogendijk, J.H. Smit, F.G. Zitman, B.W. Penninx, Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology 34(8), 1109–1120 (2009). doi:10.1016/j.psyneuen.2009.04.024
52. R.A. Hackett, A. Steptoe, M. Kumari, Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study. J. Clin. Endocrinol. metab. (2014). doi:10.1210/jc.2014-2459